tiprankstipranks
ProMIS Neurosciences (PMN)
NASDAQ:PMN

ProMIS Neurosciences (PMN) Ownership - Who Owns ProMIS Neurosciences?

20 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 25, 2023
Patrick D Kirwin
Non Executive,director
Bought$20680
Aug 25, 2023
Neil Cashman
Chief Scientific Officer
Bought$20009
Aug 25, 2023
Gail M Farfel
Chief Executive Officer
Bought$100001
Aug 25, 2023
Gavin Malenfant
Chief Operating Officer
Bought$5001

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,758,444Insider109.48%40,478,966
16,720,929Insider88.19%32,605,812
7,407,899Insider39.07%14,445,403
3,776,249Insider19.92%7,363,686
2,580,000Insider13.61%5,031,000
1,305,870Insider6.89%2,546,447
1,285,000Insider6.78%2,505,750
1,138,000Insider6.00%2,219,100
351,138Insider1.85%684,719
351,138Insider1.85%684,719

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,622Institution0.05%16,813

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns ProMIS Neurosciences (PMN)?
Currently, no data Available
What percentage of ProMIS Neurosciences (PMN) stock is held by institutional investors?
Currently, no data Available
What percentage of ProMIS Neurosciences (PMN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of ProMIS Neurosciences (PMN)?
Interinvest Corporation owns the most shares of ProMIS Neurosciences (PMN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis